Poultry Antibiotic Market

Poultry antibiotics are primarily used to treat infectious diseases as well as preventative treatment for birds (chickens, turkeys, geese, and ducks) raised commercially or domestically for meat, eggs, and feathers. Antibiotics help make food safe by keeping chickens healthy and reducing bacteria entering the food supply. Antibiotics in poultry are generally administered to the entire flock and are used for the treatment of disease, disease prevention, and growth promotion.

Market Dynamics:

An increase in the population of chickens, a rise in consumption of eggs and meat, a rise in focus on poultry healthcare, an increase in awareness among people, and an increase in demand for safe and effective poultry antibiotics are major factors expected to drive growth of the global poultry antibiotic market.

For instance, in February 2023, AgriFutures Australia, a statutory authority announced a 5-year research, development, and extension plan for Australia’s US$ 4.1 billion chicken meat industry.

Moreover, in December 2022, Avec, poultry trading company, announced the launch of its Sustainability Charter, which outlines areas where the poultry industry can improve its environmental sustainability, like packaging, animal welfare, and the use of antibiotics.

Key features of the study:

• This report provides in-depth analysis of the global poultry antibiotic market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global poultry antibiotic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co. Inc., Bayer AG, Ceva Santé Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Huvepharma, Neogen Corporation, Nisseiken Co., Ltd., Venkys India Ltd., Inovio Pharmaceuticals, Inc, among others
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global poultry antibiotic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry antibiotic market

Detailed Segmentation:

• By Product Type:
• • Penicillins
  • Tetracyclines
  • Macrolides
  • Lincosamides
  • Aminoglycosides
  • Others (Fluoroquinolones, etc.)
• By Mode of Administration:
• • Oral
  • Injection
  • Others
• By Distribution Channel:
• • Veterinary Pharmacies
  • Online Channel
  • Others (feed stores, etc.)
• By Region: 
• • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
• • Zoetis Inc.
  • Elanco Animal Health
  • Boehringer Ingelheim Animal Health
  • Merck & Co. Inc.
  • Bayer AG
  • Ceva Santé Animale
  • Virbac
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Huvepharma
  • Neogen Corporation
  • Nisseiken Co., Ltd.
  • Venkys India Ltd.